N. Perevodchikova
AuthID: R-00J-N75
1
TÃTULO: Doubling epirubicin dose intensity (100 mg/m(2) versus 50 mg/m(2)) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer
AUTORES: Brufman, G; Colajori, E; Ghilezan, N; Lassus, M; Martoni, A; Perevodchikova, N; Tosello, C; Viaro, D; Zielinski, C; Krainer, M; Salzer, H; Schuller, J; Dittrich, C; Scheithauer, W; Zamagni, C; Ambrosini, G; Colucci, G; Gentilini, P; Zaniboni, A; Pacini, P; ...Mais
PUBLICAÇÃO: 1997, FONTE: 19th ESMO Congress in ANNALS OF ONCOLOGY, VOLUME: 8, NÚMERO: 2
AUTORES: Brufman, G; Colajori, E; Ghilezan, N; Lassus, M; Martoni, A; Perevodchikova, N; Tosello, C; Viaro, D; Zielinski, C; Krainer, M; Salzer, H; Schuller, J; Dittrich, C; Scheithauer, W; Zamagni, C; Ambrosini, G; Colucci, G; Gentilini, P; Zaniboni, A; Pacini, P; ...Mais
PUBLICAÇÃO: 1997, FONTE: 19th ESMO Congress in ANNALS OF ONCOLOGY, VOLUME: 8, NÚMERO: 2
